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Abstract
After the SARS-CoV-2 pandemic took hold in the UK, the ActWELL trial team’s plans to present the trial results to
participants and other stakeholders had to change. Instead of face-face events, three online events were planned
and hosted successfully. In this article, we describe the choices made in planning and organisation of the online
events including things we would do differently if we were to do it again. We think that online events are a useful
platform when informing participants and other stakeholders of the results of your trial, even beyond the SARS-CoV-2
pandemic, and we hope this article can help other trial teams to plan their own online events.
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Background
In 2015, the United Kingdom’s (UK) Health Research
Authority (HRA), whose core purpose is “to protect and
promote the interests of patients and public in health
and social care research”, published guidance [1] recom-
mending that all researchers offer trial results to trial
participants. Following this guidance, the ActWELL
(ISRCTN11057518) [2] trial team planned to share the
trial’s results with participants. The ActWELL trial re-
sults were published in March 2021 [3].
The ActWELL multi-centre RCT evaluated the effect
of a theory-based lifestyle intervention (delivered via
two, face-to-face visits and up to 9 telephone calls with a
Breast Cancer Now (BCN) lifestyle coach) on changes in
weight and physical activity over a 1-year period.
Women were offered the chance to participate when
they attended their routine National Health Service
(NHS) Breast Screening appointment in four Scottish
health boards. The intervention itself was delivered by
BCN volunteer lifestyle coaches who were recruited and
managed by the charity.
As the trial drew to a close, a researcher was
appointed in July 2019 to work on a dissemination pack-
age, which included preparing written summaries of re-
sults and organising face-to-face dissemination events in
each of the four Scottish health boards where recruit-
ment had taken place. The SARS-CoV-2 pandemic
changed these plans.
Here we present the practical considerations we
faced when switching from face-to-face meetings to
three online events for feeding back trial results to
participants and other stakeholders during the SARS-
CoV-2 pandemic. We also consider aspects we would
likely do differently next time based on attendee
feedback.
We hope the article will provide a practical guide to
conducting online dissemination events for trial
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participants, an activity that will remain important be-
yond the SARS-CoV-2 pandemic.
Approach
Purpose of the events
The purpose of the online events was twofold:
1) To inform trial participants and other stakeholders
of the trial findings
2) To enable attendees to ask questions about any
aspect of the trial, its results and implications
arising from the findings
Event programme
The programme for the events was the same for all three
events and each event lasted for about 90 min. Four trial
team members spoke for about 60 min in total, followed
by a 5-min break and 25–30 min for a facilitated ques-
tion and answer session (see supplementary file 1).
Running of events
We decided to plan three events with the intention of
having more if the dates we proposed left many partici-
pants still unable to attend. The events were arranged
for different days and different times—one lunchtime
(12.30–14.00) and two evenings (18.30–20.00). Events
were delivered in English.
Each event was limited to 100 attendees in order to
allow the sessions to be interactive and manageable from
the trial team’s perspective. Registration and waiting lists
were managed through Eventbrite (https://www.
eventbrite.co.uk/), which is free to use for free events
such as ours. The Eventbrite event page could be kept
private so only people with a link were able to register.
Stakeholders/attendees
All women taking part in the ActWELL trial and who
had not withdrawn or moved away from Scotland were
offered an invitation to the online events. ActWELL par-
ticipants were women eligible for the UK breast screen-
ing programme (i.e. aged 50–70 years), with a mean age
at baseline of 59.1 years (SD 5.44). Trial participants
came from all socio-economic groups, with 16% from
SIMD 1 and 2 (areas of highest social deprivation) in
Scotland. Most women were of White British ethnicity
(95%).
Other stakeholders including BCN lifestyle coaches,
breast screening centre staff and leisure centre staff were
also identified by the trial team and invited by email.
Email addresses were available for most trial partici-
pants; those without an email address were sent postal
invitations.
Invitations and permissions
One invitation was designed for all stakeholders and for
both email and postal distribution (see supplementary
file 2). Due to data protection laws, the BCN volunteer
lifestyle coaches had to be invited by BCN staff who held
their contact details. Dissemination of trial results to
participants, and holding dissemination events had been
included in the initial NHS REC review. Our events were
held after the formal end of the ActWELL study and we
confirmed with the University of Dundee sponsor repre-
sentative that the proposed events were acceptable. Any-
one interested in attending was asked to register for the
event on Eventbrite.
Platform and event management
Two hosting platforms were considered for the events:
Microsoft Teams (Meetings/Live; https://www.microsoft.
com/en-gb/microsoft-teams/group-chat-software) and
Zoom (Large meeting/Webinar; https://www.zoom.us).
The platform had to enable an interactive session and
we chose the Zoom Large Meeting add-on. Many mem-
bers of the public are now familiar with Zoom, there is
evidence that research participants prefer it to other
platforms [4], and with the large meeting add-on, it was
possible to let attendees ask questions both via chat and
audio. Further benefits of using Zoom were that it inte-
grates well with Eventbrite and enables you to commu-
nicate with your registered attendees, as well as send out
an Evaluation survey using Survey Monkey (https://
www.surveymonkey.co.uk). There was some initial resist-
ance from our institution (the University of Aberdeen)
to give approval for Zoom because its institutional plat-
form is Teams and because of data security fears. How-
ever, concerns about Zoom security fears in October
2020 were reduced compared to earlier in 2020, espe-
cially with Zoom’s use of passwords and Waiting room.
Evidence that research participants preferred Zoom was
also persuasive. Permission to use Zoom for these events
was therefore granted by the University.
Event management and technical assistance was hired
for the events so that the team had someone who was
very familiar with the platform and who was able to
“produce” the event and help it run smoothly as well as
to record it (https://stauntonmedia.ie/). The sessions
were recorded mainly for internal learning purposes and
with a view to possibly make it available to participants
who could not attend events if requested. Otter.ai
(https://otter.ai) was used for live captioning of the
events as it integrates with Zoom to provide captions in
a separate browser window.
Event management also provided help for attendees
with joining and other technical issues, which meant
they could contact a member of the team behind the
scenes via email.
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Evaluation
To get feedback from attendees and to help us make
suggestions for improvements for future events, we sent
attendees an evaluation survey after the event (see sup-
plementary file 3). The survey included seven questions
with a mixture of closed and open-ended text responses.
Implementation
The ActWELL trial was led by Professor Annie S. An-
derson (ASA) from the University of Dundee, and con-
tact details for trial participants were held by the Health
Informatics Centre (HIC) at the University. Invitation
distribution was therefore managed through HIC, which
charged the trial team to do this as it was not part of the
original contract between the trial team and HIC. Other
stakeholders were sent an invitation via email by mem-
bers of the trial team (Table 1).
The invitations were emailed (n = 400) and posted (n
= 38) out 15 days before the first event. We were fortu-
nate that most participants (91%) had provided their
email address and by proxy could be expected to have
internet access. One trial participant emailed to say she
did not want to attend the online event but would ap-
preciate a written summary of the results. Out of 519
stakeholders invited, a total of 89 attended of which 53
were trial participants and 21 BCN lifestyle coaches. The
lunchtime event was the most popular with the highest
number of registrations (n = 50), including most NHS
Staff attending and a total of 39 attendees.
A number of attendees were in contact via email be-
fore and after events. One of the trial participant at-
tendees sent a list of questions providing us with a
useful set of questions to start off each Q&A session.
Other email contacts were mainly about how to access
the results other than at the events, issues around join-
ing the events and thanking the trial team for holding
the events. Demand was met with the three events
planned and therefore no further events were scheduled.
Experience of the event
All three events were delivered as planned and there
were no technical problems. All three were delivered as
per the programme shown in Supplementary 1. All three
started and finished on time.
The majority of survey respondents indicated that they
had had all their questions about the ActWELL study
and its findings answered. Five of the 47 attendees who
responded said that their questions had not been an-
swered and these questions were around future plans for
the rollout of the intervention, which the team could not
yet answer (n = 2), making the intervention more access-
ible to all socio-economic groups (n = 1) and specific
risk (n = 2). In addition, one attendee also requested ac-
cess to the paper when published in their response.
All survey respondents indicated that the information
was presented in a way that was easy to understand (n =
47). One did add a comment that there was not enough
time to look at the results on the slides.
All responses to the survey are summarised in Supple-
mentary file 4.
From our perspective as speakers (ASA, AH, JM and
ST), the online events were a great success and hugely
rewarding. Being able to speak directly to participants
and others who had helped us to do the trial was a joy
and the obvious interest and appreciation of those at-
tending made it all the more satisfying. We were asked
many excellent and probing questions in over 90 min of
questioning across the three events and these both made
us think and gave us confidence that the ActWELL
intervention [5] is worth pursuing. It is hard to now im-
agine not including online dissemination events in future
trial dissemination plans.
Table 1 Stakeholder groups and the numbers invited, registered to attend, attending the events and responding to the event
evaluation survey
Stakeholder group Invited Registered (%) Attended (% of those registered) Responded to evaluation survey
(% of those attending)
Trial participantsa 438 79 (18) 53 (67) 30 (56)
Breast Cancer Now (BCN) coaches 45 22 (49) 21 (95) 12 (57)
NHS staffb 12 8 (67) 8 (100) 3 (38)
Leisure Centre staff 8 2 (25) 2 (100) 1 (50)
BCN staff 5 5 (100) 4 (80) 0
Public representatives 5 1 (20) 1 (100) 1 (100)
Funder staff 2 0 0 0
Trial team 3 0 0 0
Total 519 117 (23) 89 47
aAll participants within ActWell who are alive, have not withdrawn, have not left Scotland and have the status “Completed Study”
bTwelve NHS staff members were invited directly (investigators and their team) while staff at breast cancer screening centres were sent invitations via a generic
email address and the number of recipients is therefore unknown
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Costs
The total cost for the three events was £1,624 GBP (€1,
842 EUR; $2,220 USD) with trial participant invitations
and event management and technical assistance at the
events being the highest expenditure items (see supple-
mentary file 5). Staff hours spent planning and organis-
ing the events have been counted separately (see
supplementary file 5) as the cost depends on local cir-
cumstances. A total of 40 h, over 2 months, were spent
by the research team on preparing the events. Having
now done these events, we would expect somewhat less
time to be needed for future events.
Recommendations
There is clearly an appetite among trial participants and
other stakeholders for events of this type and attendance
after registration was better than is usual (in personal
experience) for other academic online events. Overall, all
the events were well received and there are only a few
things we might do differently next time.
Although the evaluation was overwhelmingly positive,
we think it would have been useful to include Patient and
Public Involvement (PPI) partners in all of the planning
process for online events in line with current best practice
recommendations from the HRA [6]. Unfortunately, none
of the PPI partners who had been involved in ActWELL
was available for ours and it did not seem fair to expect
someone new to the project to get involved this late in the
trial and under considerable time pressure. For future
events, it will be particularly important to consult PPI
partners about the best way to deliver trial results to par-
ticipants. Three participants expressed a wish the events
had been face-to-face in the evaluation although we do
not know whether lockdown will have made the online
event more attractive in the future. Our key learning point
is that trial teams should plan from the start to offer both
online and face-to-face delivery of trial results to partici-
pants unless PPI partners say otherwise.
For future events, we would consider changing the
programme to give a little more focus on the results them-
selves and less on the background to the trial. We would
also consider offering a slightly later event start for at least
one event, so 19.00 rather than 18.30 start. Considering
the number of professional stakeholders who attended the
events, also in their own time, we would in future consider
offering a “quick” lunchtime session specifically aimed at
them. Alternatively, by providing more timing detail in the
joining instructions, attendees could choose to join the
event at the point they were most interested in (e.g. when
the results were presented) if they were less interested in
other parts of the session.
We would recommend the use of an event manage-
ment and technical assistance company, or your own or-
ganisation’s event management staff if available. Having
professional support completely removed any concern
about the smooth running of the event and allowed
speakers to concentrate entirely on presenting and dis-
cussing the trial with attendees. The cost of £770 was
modest when compared to the cost of organising three
face-to-face events (e.g. the original main face-to-face
event was costed at £8000 (€9252 EUR; $11,154 USD) in
total including travel for study team and attendees, over-
night accommodation for the study team, venue and
catering during the event).
After several queries from participants, we will now offer
the results in three different modes, not just the two that
were planned—dissemination events, written plain English
summary and now also a recording of dissemination events.
All three will be available on a trial-specific website, which
we will tell participants about once it becomes live (www.
actwellstudy.org). Participants will be emailed or mailed the
link to the website, so it is their choice whether to access
the information or not. Other people, including NHS staff,
emailed to ask if the event was recorded and whether they
could see it as they missed or were not available for the live
events. This will also be of benefit to any attendees with
internet connection issues and those who want to go over
the results again at their own pace.
Summary
Providing trial results direct to trial stakeholders online
was a success and should also be considered post-
pandemic. Face-to-face events will still be important but
we suggest that online events should always be offered
because they remove the need to travel (which may be a
problem for some trial participants), are easily recorded
and are efficient in terms of time and cost. However,
trial teams will have to consider how to communicate
with and disseminate to stakeholders who do not have
internet access, or who have access but are less familiar
with internet-based tools.
Lastly, there is a considerable workload associated with
planning dissemination events, whether face-to-face or
online, which should not be underestimated. We hope
this article will give pointers as to what trial teams need
to plan and budget for when designing their trials. This
work is worth it.
We will give the last word to a participant from the
ActWELL comparison group who attended the online
event of 26 November 2020:
It was tremendous to have the Feedback Day, far
beyond what I would have expected (so much
more than an A4 sheet mailed out or even less).
It was also a valuable reminder to me as to why
I should maintain the changes and some of the
techniques for achieving them. (S. MacAskill,
with permission).
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